Table 2.
Cardiac injury and COVID-19 (n = 143)
| Variable | Cardiac (n = 31) | Non-cardiac (n = 112) | P value |
|---|---|---|---|
| Age (years) | 59.03 ± 14.83 | 46.68 ± 14.40 | < 0.0001 |
| Duration of symptoms prior to hospitalization (days) | 4.5 ± 3.4 | 5.3 ± 3.2 | 0.0216 |
| Leading symptoms, % | |||
| Fever | 87% | 83% | 0.589 |
| Chest pain | 12.9% | 15.3% | 0.749 |
| Cough | 67.7% | 69.6% | 0.841 |
| Breathlessness | 45.1% | 55.3% | 0.312 |
| Diarrhea | 16.1% | 16.9% | 0.912 |
| Comorbidities/risk factors | |||
| Hypertension | 61.3% | 24.1% | < 0.0001 |
| Diabetes | 54.8% | 31.3% | 0.0155 |
| Coronary heart disease | 6.5% | 3.6% | 0.477 |
| Dyslipidemia | 19.4% | 4.5% | 0.0059 |
| Cerebrovascular disease | 9.7% | 0% | < 0.001 |
| Smoking | 12.9% | 2.7% | 0.019 |
| Chronic heart failure | 16.1% | 0% | < 0.00001 |
| Cancer | 3.2% | 1.8% | 0.617 |
| Chronic kidney disease | 16.1% | 6.2% | 0.078 |
| COPD/asthma | 19.4 | 3.6% | 0.002 |
| BMI > 30 | 22.6% | 14.3% | 0.267 |
| Interventions, % | |||
| Requiring ventilation support on admission | 77.4% | 38.4% | 0.00012 |
| Duration on invasive ventilation (days) | 14.3 ± 9.5 | 10.0 ± 10.1 | 0.531 |
| Renal replacement therapy | 48.4% | 3.6% | < 0.00001 |
| Hospitalization outcome by end of study duration, % | |||
| Remained hospitalized | 13.4% | 5.4% | 0.144 |
| Discharged | 33.3% | 87.5% | < 0.00001 |
| Death | 53.3% | 7.1% | < 0.00001 |